Open AccessResponse to: Second-Line Treatment of Non-Small-Cell Lung Cancer with Wild-Type EGFR Status. What Is the Best Approach?
Author(s) -
Ma Kim Anh,
G. Kasymjanova,
Victor Cohen,
Jason Agulnik
Publication year - 2016
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.23.2955
Subject(s) - medicine , lung cancer , oncology , cancer research , wild type , bioinformatics , biology , genetics , gene , mutant
We thank Drs. Ibrahim Elghissassi, Saber Boutayeb, Hanane Inrhaoun, Hind Mrabti, and Hassan Errihani for their comments on our paper [...]